Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Squamous NSCLC, PI3K Mutations

Rafael Rosell

MD, PhD

🏢Catalan Institute of Oncology🌐Spain

Director, Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol

85
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Dr. Rafael Rosell is a preeminent thoracic oncologist and genomics pioneer who has extensively characterized the molecular landscape of squamous NSCLC. His group identified the high prevalence of PI3K pathway mutations in squamous lung cancer and their potential as therapeutic targets. He has contributed landmark research on molecular profiling and resistance in thoracic malignancies over three decades.

Share:

🧪Research Fields 研究领域

PI3K mutations squamous NSCLC
squamous lung cancer molecular biology
FGFR PI3K co-alterations
Spanish lung cancer oncogenomics
blood-based biomarkers lung cancer

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Rafael Rosell 的研究动态

Follow Rafael Rosell's research updates

留下邮箱,当我们发布与 Rafael Rosell(Catalan Institute of Oncology)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment